NCT00602407View on ClinicalTrials.gov

Bioequivalency Study of 50 mg Cilostazol Tablets Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

March 31, 2004

Study Completion Date

March 31, 2004

Conditions
Intermittent Claudication
Interventions
DRUG

Cilostazol

Trial Locations (1)

78759

CEDRA Clinical Research, LLC, Austin

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00602407 - Bioequivalency Study of 50 mg Cilostazol Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter